PERLA BORELLI: Open Payments
NPI 1043619695 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,068 in 32 payments from 12 companies in 2025. Trend: 2023 $621 · 2024 $348 · 2025 $1,068
Food & beverage: $968Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $327 |
| Pharmacosmos Therapeutics Inc. | 1 | $141 |
| Lilly USA, LLC | 12 | $134 |
| American Regent | 1 | $129 |
| SEAGEN INC. | 1 | $100 |
| PFIZER INC. | 3 | $69 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Gilead Sciences, Inc. | 1 | $34 |
| Caris MPI, Inc. | 1 | $25 |
| Tempus AI, Inc | 1 | $25 |
Products named: ENHERTU, MONOFERRIC, VERZENIO, INJECTAFER, IBRANCE, MI CANCER SEEK, XT CDX, KEYTRUDA.
Industry payments across FL — which companies pay providers there.
